Across TCGA pan-cancer cohorts, OAF Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated OAF data layer compared with 26 for mass-spec protein and 7 for mass-spec protein.
The strongest signal is observed in lung adenocarcinoma (LUAD), where higher OAF Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated OAF expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.
LUAD and UCEC are the cancer types where OAF Mutation most reproducibly stratifies survival.